arrow
S

Stephen J. Luen

Peter MacCallum Cancer Centre
H指数:20
被引数:4,924

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study

主权与生存:澳大利亚原住民和托雷斯海峡岛民肺癌结局研究,一项病例对照研究

2026-09-210
OAAI
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory

基于RNA的基因融合检测在肉瘤诊断和管理中的临床应用价值:澳大利亚实验室的经验

2025-11-110
PRE
Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors

病理科医师发起的全基因组与转录组测序展示了在解决难诊断肿瘤方面的诊断效用

2025-10-080
OAAI
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian Cohort

侵袭性纤维瘤的治疗模式趋势与临床结局:一项来自澳大利亚单机构的大型队列研究

2025-05-190
OA
Interim analysis (IA) of the giredestrant (G) plus ipatasertib (IPAT) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/ metastatic BC (LA/mBC)
2023-10-010
PRE
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer

PARP和WEE1联合抑制触发BRCA1/2野生型三阴性乳腺癌的抗肿瘤免疫反应

2023-08-157
OA
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
2023-04-145
OAAI
A highly sensitive and specific PARylation assay confirms significant and durable target engagement by AZD5305 in patients
2023-04-140
OA
Pharmacokinetic/pharmacodynami c (PK/PD) relationships of the novel Treg depleter RG6292 in Phase Ia and Ib studies in patients with solid tumors
2023-04-142
PRE
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
2023-04-0115
OAAI